1. Home
  2. FGEN vs KORE Comparison

FGEN vs KORE Comparison

Compare FGEN & KORE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • KORE
  • Stock Information
  • Founded
  • FGEN 1993
  • KORE 2003
  • Country
  • FGEN United States
  • KORE United States
  • Employees
  • FGEN N/A
  • KORE N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • KORE Telecommunications Equipment
  • Sector
  • FGEN Health Care
  • KORE Consumer Discretionary
  • Exchange
  • FGEN Nasdaq
  • KORE Nasdaq
  • Market Cap
  • FGEN 38.4M
  • KORE 39.3M
  • IPO Year
  • FGEN 2014
  • KORE N/A
  • Fundamental
  • Price
  • FGEN $11.48
  • KORE $2.34
  • Analyst Decision
  • FGEN Strong Buy
  • KORE Hold
  • Analyst Count
  • FGEN 2
  • KORE 2
  • Target Price
  • FGEN $146.50
  • KORE $2.75
  • AVG Volume (30 Days)
  • FGEN 64.8K
  • KORE 9.5K
  • Earning Date
  • FGEN 08-11-2025
  • KORE 08-14-2025
  • Dividend Yield
  • FGEN N/A
  • KORE N/A
  • EPS Growth
  • FGEN N/A
  • KORE N/A
  • EPS
  • FGEN N/A
  • KORE N/A
  • Revenue
  • FGEN $7,346,000.00
  • KORE $285,636,000.00
  • Revenue This Year
  • FGEN N/A
  • KORE $4.46
  • Revenue Next Year
  • FGEN N/A
  • KORE $5.94
  • P/E Ratio
  • FGEN N/A
  • KORE N/A
  • Revenue Growth
  • FGEN N/A
  • KORE 0.24
  • 52 Week Low
  • FGEN $4.50
  • KORE $1.10
  • 52 Week High
  • FGEN $21.94
  • KORE $4.88
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 59.87
  • KORE 49.53
  • Support Level
  • FGEN $10.65
  • KORE $2.20
  • Resistance Level
  • FGEN $12.60
  • KORE $2.32
  • Average True Range (ATR)
  • FGEN 0.82
  • KORE 0.14
  • MACD
  • FGEN -0.06
  • KORE 0.00
  • Stochastic Oscillator
  • FGEN 55.20
  • KORE 48.98

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.

Share on Social Networks: